Fatal multiple acyl-CoA dehydrogenase deficiency caused by ETFDH gene mutation: A case report

Figure 2 Changes of clinical biochemistry after treatment. A: Coagulation system: levels of thromboplastin time (APTT), thrombin time (TT), prothrombin time (PT) and international normalized ratio (INR); B: Liver function: levels of alanine transaminase (ALT), aspartic transaminase (AST), direct bilirubin (DBIL), indirect bilirubin (IBIL); C: Kidney function and myolysis: levels of serum creatinine (Scr), creatine kinase (CK), lactate dehydrogenase (LDH-L), hydroxybutyrate dehydrogenase (HBDH); D: Infection indicators: levels of procalcitonin (PCT), high sensitive C-reactive protein (CRP), white blood cells (WBC), platelets (PLT).